US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Avalyn Pharma

28.13

+0.71002.59%

Post-market: 28.130.00000.00%19:30 EDT

Volume:526.20K

Turnover:14.87M

Market Cap:1.25B

PE:-12.07

High:28.92

Open:28.59

Low:27.72

Close:27.42

52wk High:40.17

52wk Low:24.15

Shares:44.33M

Float Shares:16.67M

Volume Ratio:1.62

T/O Rate:3.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3300

EPS(LYR):-87.7434

ROE:-68.34%

ROA:-41.74%

PB:3.13

PE(LYR):-0.32

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Avalyn Pharma initiated with an Outperform at Raymond James

Avalyn Pharma Reports Phase 1 Data for Inhaled Nintedanib AP02 Showing Higher Lung Exposure, Lower Systemic Levels

Avalyn Pharma announces published results from Phase 1 trials of AP02

Avalyn Pharma Director Robert J. Meyer Files Initial Beneficial Ownership Statement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/AVLN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AVLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","market":"US","secType":"STK","nameCN":"Avalyn Pharma","latestPrice":28.13,"timestamp":1790971200000,"preClose":27.42,"halted":0,"volume":526199,"hourTrading":{"tag":"盘后","latestPrice":28.13,"preClose":28.13,"latestTime":"19:30 EDT","volume":3225,"amount":90719.25,"timestamp":1790983804404,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02589350838803783,"floatShares":16666700,"shares":44333095,"eps":-2.33,"marketStatus":"Market Closed","change":0.71,"latestTime":"10-02 16:00:00 EDT","open":28.59,"high":28.92,"low":27.72,"amount":14868540.991102,"amplitude":0.043764,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.33,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"listingDate":1777521600000,"exchange":"NASDAQ","adjPreClose":27.42,"preHourTrading":{"tag":"盘前","latestPrice":29.06,"preClose":27.42,"latestTime":"09:29 EDT","volume":3010,"amount":84799.02634,"timestamp":1790947770074,"change":1.64,"changeRate":0.05981,"amplitude":0.047775},"postHourTrading":{"tag":"盘后","latestPrice":28.13,"preClose":28.13,"latestTime":"19:30 EDT","volume":3225,"amount":90719.25,"timestamp":1790983804404,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.6219064428262724,"impliedVol":0.6694,"impliedVolPercentile":0.5333},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","floatShares":16666700,"roa":"-41.74%","roe":"-68.34%","lyrEps":-87.743381,"volumeRatio":1.6219064428262724,"shares":44333095,"dividePrice":0,"high":28.92,"amplitude":0.043764,"preClose":27.42,"low":27.72,"week52Low":24.15,"pbRate":"3.13","week52High":40.17,"institutionHeld":0,"latestPrice":28.13,"eps":-2.33,"divideRate":0,"volume":526199,"delay":0,"ttmEps":-2.33,"open":28.59,"prevYearClose":18,"prevWeekClose":28.08,"prevMonthClose":28.49,"prevQuarterClose":28.49,"fiveDayClose":28.08,"twentyDayClose":35.44,"sixtyDayClose":28.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVLN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"AVLN","fiscalQuarterEnding":"2026/06","expectedEps":-1.03,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"pre","actualEps":-0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVLN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1781755200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVLN","date":"2026-10-02","current":-12.072961,"percent":0.981132,"low":-16.842577,"twenty":-15.383041,"median":-14.069191,"eighty":-13.181374,"high":-8.833116,"avg":-14.202014,"sd":1.333723,"marketCap":1215613464},"quantilePoints":[{"date":"2026-05-01","current":-14.471589,"twenty":-13.343894,"median":-11.652352,"eighty":-9.960811,"marketCap":1233037266},{"date":"2026-05-08","current":-13.215324,"twenty":-14.430368,"median":-13.598092,"eighty":-13.264397,"marketCap":1125998425},{"date":"2026-05-15","current":-15.026112,"twenty":-14.666899,"median":-14.368536,"eighty":-13.42143,"marketCap":1280284879},{"date":"2026-05-22","current":-13.941602,"twenty":-14.643344,"median":-13.941602,"eighty":-13.42143,"marketCap":1187880255},{"date":"2026-05-29","current":-13.931787,"twenty":-14.643344,"median":-13.931787,"eighty":-13.215324,"marketCap":1187044014},{"date":"2026-06-05","current":-13.244767,"twenty":-14.510847,"median":-13.774754,"eighty":-13.102456,"marketCap":1128507148},{"date":"2026-06-12","current":-13.774754,"twenty":-14.471589,"median":-13.774754,"eighty":-13.161343,"marketCap":1173664159},{"date":"2026-06-18","current":-14.383258,"twenty":-14.479441,"median":-13.794383,"eighty":-13.204528,"marketCap":1225511097},{"date":"2026-06-26","current":-13.585419,"twenty":-14.649233,"median":-13.936694,"eighty":-13.238878,"marketCap":1284773093},{"date":"2026-07-02","current":-14.143275,"twenty":-14.655122,"median":-14.03484,"eighty":-13.265378,"marketCap":1337529476},{"date":"2026-07-10","current":-13.557292,"twenty":-14.643344,"median":-13.937009,"eighty":-13.265378,"marketCap":1282113107},{"date":"2026-07-17","current":-12.038425,"twenty":-14.576758,"median":-13.784568,"eighty":-13.15846,"marketCap":1138473879},{"date":"2026-07-24","current":-13.937009,"twenty":-14.519455,"median":-13.774754,"eighty":-13.193732,"marketCap":1318022914},{"date":"2026-07-31","current":-13.740119,"twenty":-14.495144,"median":-13.755125,"eighty":-13.157019,"marketCap":1299403014},{"date":"2026-08-07","current":-15.329303,"twenty":-14.523759,"median":-13.762486,"eighty":-13.165961,"marketCap":1449692206},{"date":"2026-08-14","current":-15.696852,"twenty":-14.725787,"median":-13.774754,"eighty":-13.189862,"marketCap":1621704615},{"date":"2026-08-21","current":-15.932863,"twenty":-15.087944,"median":-13.934398,"eighty":-13.227101,"marketCap":1646087817},{"date":"2026-08-28","current":-15.666815,"twenty":-15.573456,"median":-13.941602,"eighty":-13.249768,"marketCap":1618601298},{"date":"2026-09-04","current":-15.207667,"twenty":-15.433025,"median":-14.088821,"eighty":-13.261019,"marketCap":1571164886},{"date":"2026-09-11","current":-14.877252,"twenty":-15.620135,"median":-14.133223,"eighty":-13.26914,"marketCap":1537028403},{"date":"2026-09-18","current":-14.345155,"twenty":-15.433221,"median":-14.265483,"eighty":-13.287874,"marketCap":1482055365},{"date":"2026-09-25","current":-12.251097,"twenty":-15.425244,"median":-14.133223,"eighty":-13.26914,"marketCap":1265709862},{"date":"2026-10-02","current":-11.766203,"twenty":-15.383041,"median":-14.069191,"eighty":-13.181374,"marketCap":1215613464}],"updateTime":1791062096562},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVLN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672489715","title":"Avalyn Pharma initiated with an Outperform at Raymond James","url":"https://stock-news.laohu8.com/highlight/detail?id=2672489715","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672489715?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:45","pubTimestamp":1790934320,"startTime":"0","endTime":"0","summary":"Raymond James analyst Tiago Fauth initiated coverage of Avalyn Pharma (AVLN) with an Outperform rating and $60 price target Avalyn is developing in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-initiated-with-an-outperform-at-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-initiated-with-an-outperform-at-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVLN","RJF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669162378","title":"Avalyn Pharma Reports Phase 1 Data for Inhaled Nintedanib AP02 Showing Higher Lung Exposure, Lower Systemic Levels","url":"https://stock-news.laohu8.com/highlight/detail?id=2669162378","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669162378?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:11","pubTimestamp":1790007085,"startTime":"0","endTime":"0","summary":"Avalyn Pharma reports Phase 1 data for inhaled nintedanib AP02 showing higher lung exposure, lower systemic levelsAvalyn Pharma flagged aRespiratory Researchpublication detailing Phase 1 trials of inh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDLbxKbJx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4007","LU0314104364.USD","BK4585","LU2095319765.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00BQXX3D17.EUR","SG9999014021.USD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","SG9999014039.USD","AVLN","SG9999014005.SGD","BK4112","BK4588","IE00BN0W2W23.USD","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BCDF","SG9999014013.SGD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669661341","title":"Avalyn Pharma announces published results from Phase 1 trials of AP02","url":"https://stock-news.laohu8.com/highlight/detail?id=2669661341","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669661341?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:10","pubTimestamp":1789996248,"startTime":"0","endTime":"0","summary":"Avalyn Pharma (AVLN) announced that Respiratory Research has published detailed results from two Phase 1 clinical trials of AP02 in healthy volunte...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-announces-published-results-from-phase-1-trials-of-ap02-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-announces-published-results-from-phase-1-trials-of-ap02-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","GDOC","MEDX","NVIB","BMED","HYLG","BBC","AVLN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668054994","title":"Avalyn Pharma Director Robert J. Meyer Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2668054994","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668054994?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:06","pubTimestamp":1789675617,"startTime":"0","endTime":"0","summary":"Avalyn Pharma Director Robert J. Meyer files initial beneficial ownership statementAvalyn Pharma director Robert J. Meyer filed an initial Form 3 beneficial ownership statement dated Sept. 15, 2026.Di","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL9Q9vwJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVLN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":13,"pageCount":1,"totalSize":52,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AVLN\",params:#limit:6,delay:false,,,undefined,":[]}}